Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-10-23 | New | $105,254,891 | $105,254,891 | Equity Only | 06b | SEC link |
| 2022-08-31 | New | $193,537 | $193,537 | Equity Only | 06b | SEC link |
| 2018-02-09 | New | $3,999,996 | $3,999,996 | Other | 06b | SEC link |
| 2017-09-19 | New | $4,302,202 | $4,302,202 | Other | 06b | SEC link |
| Name | Role |
|---|---|
| Ruhama Avraham | Director |
| Ruth Ben Yakar | Director |
| Michael Berelowitz | Director |
| Yuval Berman | Director |
| David Braun | Director |
| Denise Carter | Director, Executive |
| Kasbian Nuriel Chirich | Director |
| Joseph Cooper | Director |
| James Culverwell | Director |
| Gordon Dunn | Executive |
| David Grossman | Director |
| Dennis Langer | Director |
| Sally Bridget Lawlor | Executive |
| Eyal Leibovitz | Executive |
| Natalie Leong | Director |
| Michael Myers | Director, Executive |
| Abraham Nahmias | Director |
| Michael Sember | Director |
| Shai Yarkoni | Director, Executive |